Specific temperament in patients with nevoid basal cell carcinoma syndromecolleen2024-05-08T17:17:54+00:00February 23, 2022|Read More
Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trialcolleen2022-12-07T13:18:32+00:00February 3, 2022|Read More
The Gorlin Syndrome Alliance and NORD Launch Natural History Study for Gorlin Syndromecolleen2022-11-20T16:36:16+00:00November 19, 2021|Read More
Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysiscolleen2024-05-08T16:41:28+00:00November 19, 2021|Read More
Treatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meetingcolleen2022-12-07T13:19:32+00:00November 15, 2021|Read More
Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysiscolleen2024-05-08T16:41:08+00:00October 11, 2021|Read More
Proposed criteria for nevoid basal cell carcinoma syndrome in children assessed using statistical optimizationcolleen2024-05-08T16:58:26+00:00October 5, 2021|Read More
CODY Trial: Clinical Trial of a topical gel for the prevention of basal cell carcinomas in adults with Gorlin syndrome.admin2022-08-18T00:04:36+00:00October 4, 2021|Read More
